This is only part of the target. The other piece, lower on the spine, received radiation already, and wasn't discouraged. Surgery, we know, is a temporary fix.
So this morning we visit with oncologist to hear about the promised new tricks. We are given the name of a drug previously unmentioned. Not a new cancer drug -- it has been used in thousands of lung cancer patients -- but its track record for chordoma is exactly one patient. In Germany. With results that "seem encouraging."
One patient? Encouraging? Wouldn't a dose of asparagus produce the same, without the side effects?
And what, I ask, about the two drugs mentioned in previous visits?
Well, maybe, he says. But he is intent on this newer possibility, if he can get approval from the insurance company. He leaves the room, and five minutes later comes back, smiling happily and giving us a thumbs up. Yes! We can go to the pharmacy and get it filled.
Neither Rich nor I smile. I don't share the physician's enthusiasm. Rich is not my trial monkey.
Aren't we doing this backwards? To cure, why are we hurting?
So much I don't understand.
But we go out to a favorite bistro for lunch and have our soups and salads and wine, and walk along the Hudson, and the rest of day I'm humming I'll see my love tonight from "West Side Story" and believe this song will never end.
Candace